Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Vycor Medical, Inc. (VYCO : OTC)

• Company Description    Vycor Medical Inc. designs, develops and markets neurological medical devices and therapies in the United States and Europe. Its operating segment includes Vycor Medical and NovaVision. Vycor Medical Inc. is based in Boca Raton, Florida. Number of Employees: 7

• Price / Volume Information    Yesterday's Closing Price: $0.12 Daily Weekly Monthly 20 Day Moving Average: 1,170 shares Shares Outstanding: 33.42 (millions) Market Capitalization: $4.18 (millions) Beta: -0.61 52 Week High: $0.28 52 Week Low: $0.04 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -3.77% -5.46% 12 Week 8.70% -1.27% Year To Date 78.83% 59.67%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 951 BROKEN SOUND PARKWAY SUITE 320 - BOCA RATON,FL 33487 USA ph: 561-558-2020 fax: 631-794-2444 david@b2idigital.com http://www.vycormedical.com

• General Corporate Information    Officers Peter C. Zachariou - Chief Executive Officer Adrian Christopher Liddell - Chairman And Chief Financial Officer David Marc Cantor - President Steven Girgenti - Director Lowell Rush - Director Peer Information Vycor Medical, Inc. (ABMD) Vycor Medical, Inc. (DMDS) Vycor Medical, Inc. (CPWY.) Vycor Medical, Inc. (EQUR) Vycor Medical, Inc. (ECIA) Vycor Medical, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 92921M203 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/12/25 Share - Related Items Shares Outstanding: 33.42 Most Recent Split Date: (:1) Beta: -0.61 Market Capitalization: $4.18 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/12/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 2.35 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: 100.00% Sales Growth vs. Year Ago Period: 22.17% vs. Previous Quarter: 13.76% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - -8.08 03/31/25 - -11.44 12/31/24 - -10.66 Current Ratio 06/30/25 - 0.12 03/31/25 - 0.13 12/31/24 - 0.15 Quick Ratio 06/30/25 - 0.09 03/31/25 - 0.09 12/31/24 - 0.11 Operating Margin 06/30/25 - -4.43 03/31/25 - -6.79 12/31/24 - -6.78 Net Margin 06/30/25 - -4.60 03/31/25 - -6.86 12/31/24 - -6.78 Pre-Tax Margin 06/30/25 - -4.46 03/31/25 - -6.81 12/31/24 - -6.73 Book Value 06/30/25 - -0.12 03/31/25 - -0.12 12/31/24 - -0.11 Inventory Turnover 06/30/25 - 1.37 03/31/25 - 1.03 12/31/24 - 0.79 Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©